FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 30 filers reported holding FENNEC PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 2.31 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $88,866 | -30.7% | 11,833 | -18.6% | 0.00% | – |
Q2 2023 | $128,317 | +12731.7% | 14,532 | +20660.0% | 0.00% | – |
Q1 2023 | $1,000 | +99900.0% | 70 | 0.0% | 0.00% | – |
Q4 2022 | $1 | -99.9% | 70 | 0.0% | 0.00% | – |
Q3 2022 | $1,000 | -98.6% | 70 | -99.1% | 0.00% | – |
Q2 2022 | $69,000 | -24.2% | 7,735 | -52.7% | 0.00% | – |
Q1 2022 | $91,000 | – | 16,366 | +23280.0% | 0.00% | – |
Q4 2021 | $0 | -100.0% | 70 | -99.7% | 0.00% | – |
Q2 2021 | $146,000 | +2.8% | 20,021 | -12.6% | 0.00% | – |
Q1 2021 | $142,000 | +97.2% | 22,914 | +137.0% | 0.00% | – |
Q4 2020 | $72,000 | +50.0% | 9,670 | +21.3% | 0.00% | – |
Q3 2020 | $48,000 | -21.3% | 7,971 | +9.7% | 0.00% | – |
Q2 2020 | $61,000 | +6000.0% | 7,265 | +6504.5% | 0.00% | – |
Q3 2019 | $1,000 | -92.9% | 110 | -96.1% | 0.00% | – |
Q1 2019 | $14,000 | -39.1% | 2,831 | -22.1% | 0.00% | – |
Q4 2018 | $23,000 | +4.5% | 3,633 | +35.2% | 0.00% | – |
Q3 2018 | $22,000 | -94.5% | 2,687 | -93.0% | 0.00% | – |
Q2 2018 | $398,000 | – | 38,136 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sonic GP LLC | 2,407,357 | $18,079,251 | 17.55% |
Solas Capital Management, LLC | 1,725,567 | $12,959,008 | 9.07% |
DG Capital Management, LLC | 1,143,099 | $8,584,673 | 4.70% |
HARBERT FUND ADVISORS, INC. | 466,869 | $3,506,186 | 2.56% |
AIGH Capital Management LLC | 373,526 | $2,805,180 | 1.33% |
Southpoint Capital Advisors LP | 4,077,214 | $30,619,877 | 0.68% |
APIS CAPITAL ADVISORS, LLC | 70,000 | $525,700 | 0.68% |
Worth Venture Partners, LLC | 92,636 | $695,696 | 0.41% |
Lion Point Capital, LP | 110,000 | $826,100 | 0.37% |
683 Capital Management, LLC | 300,000 | $2,253,000 | 0.18% |